• Home
  • Conference News
    • Pre-Coverage
    • Conference Coverage
    • Post Coverage
    • Archives
      • 2024
      • 2023
      • 2022
  • Industry
  • Industry Programs
    • Innovation Theaters
    • Innovation Hubs
    • Evening Symposia
  • Industry Connections
  • Publications
    • Preview Magazine
    • On-Site Guide
  • Photos
  • Program at a Glance
  • Special Topics
    • Allergy and Immunology
    • Bronchiectasis and COPD
  • Follow The ATS
    • Facebook
    • BlueSky
    • LinkedIn
    • Instagram
    • X
    • YouTube
  • Get News Updates

ATS Conference News

San Francisco | May 16-21

We help the world breathe.

GET NEWS UPDATES
CONFERENCE HOME
REGISTER NOW
  • Trials Show Promise for New Agents to Treat COPD

    Trials Show Promise for New Agents to Treat COPD

    on

    06/21/2023

    Several trial results for the treatment of COPD were shared at the 2023 International Conference. Gerard J. Criner, MD, and David M. Mannino III, MD, discussed findings from the BOREAS trial, expectations from the ongoing NOTUS trial, and data from the ENHANCE-1 and ENHANCE-2 studies.

    Read more: Trials Show Promise for New Agents to Treat COPD
  • Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis

    Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis

    on

    06/21/2023

    Timothy R. Aksamit, MD, FCCP, and Mark Metersky, MD, FCCP, comment on updates from multiple studies making headway in treating bronchiectasis. These trials, presented at the ATS 2023 International Conference, reflect research focusing on the three pillars of the disease: infection, inflammation, and mucociliary milieu. The trials included phase three of PROMIS II and phase…

    Read more: Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis
  • Researchers Report Positive Trial Results on Four Investigative Agents for Asthma, COPD, and PAH

    Researchers Report Positive Trial Results on Four Investigative Agents for Asthma, COPD, and PAH

    on

    06/13/2023

    Four highly anticipated trials were presented at the ATS 2023 International Conference. The trials included the TORREY Study of Seralutinib, the ENHANCE Trials of Nebulized Ensifentrine, the Phase 1b Study of SAR443765 in Mild-to-Moderate Asthma, and the BOREAS Study of Dupilumab in COPD Patients with Type 2 Inflammation. Robert P. Frantz, MD, summarized the findings…

    Read more: Researchers Report Positive Trial Results on Four Investigative Agents for Asthma, COPD, and PAH
  • Clinical Year in Review 3 Focuses on Asthma, Sarcoidosis, Sepsis, Sleep

    Clinical Year in Review 3 Focuses on Asthma, Sarcoidosis, Sepsis, Sleep

    on

    06/13/2023

    The third session of the annual Clinical Year in Review explored the latest developments in asthma, sarcoidosis, sepsis, and sleep. Using Single Maintenance and Reliever Therapy recommendations for patients with asthma addresses issues of self-management and adherence often seen in this population, reported Vanessa Marie McDonald, PhD.

    Read more: Clinical Year in Review 3 Focuses on Asthma, Sarcoidosis, Sepsis, Sleep
  • Final Clinical Year in Review Examines New Research in Lung Transplantation, Medical Education, Health Disparities, CF and non-CF Bronchiectasis

    Final Clinical Year in Review Examines New Research in Lung Transplantation, Medical Education, Health Disparities, CF and non-CF Bronchiectasis

    on

    06/13/2023

    The final Clinical Year in Review session covered lung transplantation, medical education, health disparities, and cystic fibrosis/non-cystic fibrosis bronchiectasis. Race-based corrections in spirometry are not clinically derived, said Deepshikha Charan Ashana, MD, MBA, MS.

    Read more: Final Clinical Year in Review Examines New Research in Lung Transplantation, Medical Education, Health Disparities, CF and non-CF Bronchiectasis
  • Panel Discusses Alternatives to Race-Specific Equations in Pulmonary Function Testing

    Panel Discusses Alternatives to Race-Specific Equations in Pulmonary Function Testing

    on

    06/13/2023

    Co-authors of “Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement” participated in a panel of experts to discuss the potential harms and benefits of race-specific reporting in PFTs and propose alternatives that better reflect the populations served. The shift from race-specific PFT equations to race-neutral, or indeed some other…

    Read more: Panel Discusses Alternatives to Race-Specific Equations in Pulmonary Function Testing
  • Clinical Year in Review Begins with Latest Developments in ARDS, Pulmonary Vascular Disease, COPD, ILD

    Clinical Year in Review Begins with Latest Developments in ARDS, Pulmonary Vascular Disease, COPD, ILD

    on

    06/02/2023

    The first of four Clinical Year in Review sessions highlighted the latest papers published on acute respiratory distress syndrome, pulmonary vascular disease, chronic obstructive pulmonary disease, and interstitial lung disease. Stephanie Christenson, MD, MS, discussed new approaches to change the course of COPD recommended by the Lancet Commission and incorporated into the 2023 GOLD Report.

    Read more: Clinical Year in Review Begins with Latest Developments in ARDS, Pulmonary Vascular Disease, COPD, ILD
  • Experts Discuss Impactful Papers on Lung Cancer, COVID-19, Palliative Care, and Critical Care in Second Clinical Year in Review

    Experts Discuss Impactful Papers on Lung Cancer, COVID-19, Palliative Care, and Critical Care in Second Clinical Year in Review

    on

    06/02/2023

    The second session of the Clinical Year in Review explored the latest developments in lung cancer, COVID-19, palliative care, and critical care. Tiffanie Jones, MD, MPH, MSCE, discussed how early mobilization of patients in the intensive care unit affects ICU-acquired weaknesses.

    Read more: Experts Discuss Impactful Papers on Lung Cancer, COVID-19, Palliative Care, and Critical Care in Second Clinical Year in Review
  • International Respiratory Societies Gather to Discuss Inequities in COPD Treatment

    International Respiratory Societies Gather to Discuss Inequities in COPD Treatment

    on

    06/02/2023

    The Respiratory Societies of the Americas kicked off its first in-person session at the ATS 2023 International Conference with representatives from four societies discussing COPD, its effects on country-specific populations, and the impact of health policies in relation to COPD. In Brazil, COPD is present in 6 percent of deaths, reported Frederico Fernandes, MD, PhD.

    Read more: International Respiratory Societies Gather to Discuss Inequities in COPD Treatment
  • President’s Forum Focuses on Early Life Antecedents of Adult Lung Disease

    President’s Forum Focuses on Early Life Antecedents of Adult Lung Disease

    on

    06/02/2023

    Experts convened to explain the importance of early detection of prenatal and childhood respiratory illnesses and exposure to possible factors that could lead to adult respiratory disease. Some of these factors include airborne pollutants, viral infections like asthma, small airways disease, and COPD. Preterm birth exacerbates problems with pulmonary function across the lifespan, explained Kara…

    Read more: President’s Forum Focuses on Early Life Antecedents of Adult Lung Disease
1 2 3 … 10
Next Page

Follow The ATS

  • Bluesky
  • Facebook
  • LinkedIn
  • Instagram
  • X
  • YouTube
  • TikTok

Upcoming Industry Programs

View All

Popular Articles

  • Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s Keynote

  • Monday Keynote Presents Exciting Progress in Gene Therapies for Cystic Fibrosis

  • Women’s Forum Speaker Reflects on the Meaning of Success, Purpose, and the Future of Female Leadership in Medicine

  • Breaking Clinical Trials Session Unveils New Insights in Pulmonary Medicine

  • Meet the 2025 Respiratory Health Awards Recipients

©2025 American Thoracic Society. All Rights Reserved. Powered by TriStar Event Media, LLC.
Privacy Policy

FOLLOW THE ATS:

  • Bluesky
  • Facebook
  • LinkedIn
  • Instagram
  • X
  • YouTube
  • TikTok

Get news updates from ATSConferenceNews.org

Subscribe below to get email updates from ATSConferenceNews.org